Backgound video

Mpox Vaccination

Mpox is a viral infection transmitted through close physical contact, including intimate and sexual contact, and vaccination now helps protect those at increased risk.

Mpox is a viral infection that can be transmitted through close physical contact, including intimate and sexual contact. Although most infections are self-limiting, mpox can cause a painful and distressing illness and, in some cases, lead to serious complications.

Following outbreaks in Europe, North America and other parts of the world, mpox has become an increasingly important consideration within modern sexual health medicine. Vaccination now plays a valuable role in protecting individuals at increased risk of exposure.

What Is Mpox?

Mpox is caused by the monkeypox virus, a member of the orthopoxvirus family. Symptoms typically develop several days to a few weeks after exposure and may include fever, swollen lymph nodes, muscle aches, fatigue and a characteristic rash.

The rash may appear anywhere on the body but frequently affects the genital, anal and surrounding skin. Lesions can be painful and are sometimes mistaken for herpes, syphilis or other sexually transmitted infections.

Whilst most individuals recover fully, symptoms can occasionally be severe and may require medical treatment or hospital admission.

How Is Mpox Transmitted?

Mpox spreads primarily through close physical contact.

Transmission may occur through:

  • Direct skin-to-skin contact with lesions or rash
  • Intimate sexual contact
  • Contact with bodily fluids
  • Prolonged face-to-face exposure
  • Contact with contaminated bedding, towels or clothing

Although mpox is not classified solely as a sexually transmitted infection, many recent outbreaks have spread predominantly through sexual networks involving close physical contact.

Who Should Consider Vaccination?

Mpox vaccination is generally recommended for individuals considered to be at increased risk of exposure.

This may include:

  • Men who have sex with men
  • Individuals with multiple sexual partners
  • Those participating in higher-risk sexual networks
  • Sexual health clinic attendees identified as being at increased risk
  • Certain healthcare workers or laboratory staff

Eligibility criteria may change over time depending on national guidance and local epidemiology.

How Effective Is Mpox Vaccination?

The vaccine currently used for mpox in the UK is based on a non-replicating smallpox vaccine and provides significant protection against mpox infection.

Whilst no vaccine offers complete protection, vaccination appears to reduce both the likelihood of infection and the severity of illness should infection occur.

Vaccination has played an important role in controlling recent outbreaks and reducing rates of severe disease.

What Is The Vaccination Schedule?

The recommended schedule depends on individual circumstances and current public health guidance.

Many individuals receive a two-dose course, although recommendations may vary according to previous vaccination history, risk profile and vaccine availability.

We can advise on eligibility, timing and current recommendations during consultation.

Is The Vaccine Safe?

The mpox vaccine has been extensively evaluated and has a reassuring safety profile.

Most side effects are mild and temporary and may include:

  • Arm soreness
  • Fatigue
  • Headache
  • Mild muscle aches
  • Low-grade fever

Serious side effects are uncommon.

Why Do We Recommend Mpox Vaccination?

Mpox can cause a painful, distressing and occasionally severe illness. Vaccination offers an effective means of reducing risk, particularly for those with increased likelihood of exposure.

As with many aspects of preventative medicine, protecting against infection is often considerably preferable to managing illness after it has developed.

Our Approach

At The Wright Practice, we assess mpox vaccination as part of a broader personalised sexual health strategy. We consider individual risk factors, sexual practices, travel history and current public health recommendations to determine whether vaccination is likely to provide meaningful benefit.

Key Points

  • Mpox is a viral infection spread through close physical contact.
  • Symptoms commonly include rash, swollen lymph nodes, fever and fatigue.
  • Recent outbreaks have disproportionately affected certain sexual networks.
  • Vaccination can significantly reduce the risk of infection and severe illness.
  • Individuals at increased risk may benefit from vaccination.
  • The vaccine has a reassuring safety profile and an established evidence base.

Meet our team

Dr Daniel Wright
MD MRCGP MA (Hons) BA (Hons)
Dr. Susan Jain
MD MRCGP MA (Hons) BA (Hons)
Nathan Hunt
Practice Manager

What our patients say on Google

Wow! Dr. Dan was extremely knowledgeable and attentive to my health and well being. I’m so glad to have found him!

John Rutherford
John Rutherford

I have been going to Dr Wright for a number of years now. He is highly knowledgeable, compassionate, open minded and efficient, I couldn’t recommend him highly enough

Peter Jones
Peter Jones

I have been a patient of Doctor Dan for some time and continue to consult with him despite having left the UK. Dan has the enthusiasm and energy of a young man, whilst taking the holistic “physician” approach of an old school family doctor, equipped with the most modern insights and technology.

Steve Smith
Steve Smith

Dr Jain was great. Expert knowledge with practical advice

George Mosley
George Mosley

Book Online

Schedule a consultation | Call: +44 (0)207 139 1833 | Email: info@thewrightpractice.com

101 Harley Street, London, W1G 6AH

The Wright Practice

101 Harley Street, London, W1G 6AH, United Kingdom

Rated ★ ★ ★ ★ ★ from 192 Reviews

Opening hours
Monday
9.00 - 17.00
Tuesday
9.00 - 17.00
Wednesday
9.00 - 17.00
Thursday
9.00 - 17.00
Friday
9.00 - 17.00
Saturday
9.00 - 17.00
Sunday
Closed
The Wright Practice
101 Harley Street, London, W1G 6AH, United Kingdom
Get directions
Book Online
Whatsapp